Transwell assay showed that PDIA3P1 overexpression promoted the migration and invasion capacity of glioma cells, while PDIA3P1 knockdown inhibited the capacity (Fig. 2d, Supplementary Fig. 1e–i). Here, PDIA3P1 is linked to central nervous system cancer.